There are ways … drug companies will get into DTC decisions”: How Australian drug and therapeutics committees address pharmaceutical industry influence

Study (interviews with 29 members of hospital DTCs) found that processes are vulnerable to pharmaceutical industry influence at several points, e.g. company representatives completing new drug applications as opposed to clinicians, and incomplete conflicts of interests.

British Journal of Clinical Pharmacology